Facebook
X
LinkedIn
ForwardPodcast: Awakening the Future: How Emerging Narcolepsy Type 1 Therapies Are Redefining Care and Expectations
Listen to the episode here!
Learning Objectives
At the completion of this activity, participants should be able to:
1. Discuss the impact of soon-to-emerge narcolepsy type 1 therapies and evolving guidelines on clinical practice, focusing on how these advances may reshape patient expectations, access, and health outcomes.
Commercial Support
This podcast is supported by an independent medical education grant from Takeda Pharmaceuticals U.S.A., Inc.
Faculty:
Amy Lugo, PharmD, BCPS, BC-ADM, FAPhA, FAMCP
Founder & CEO
LoneStar Health Solutions
Moderator:
Steven Kheloussi, PharmD, MBA, FAMCP
Principal Consultant
Kheloussi Consulting, LLC
Financial Relationship Disclosures:
| Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
| Steven Kheloussi Moderator | Disclosed no relevant financial relationships. |
| Amy Lugo Faculty | Disclosed no relevant financial relationships. |
- AMCP Staff have disclosed no relevant financial relationships.
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
ACPE UAN: 0233-0000-26-037-H01-P
Activity Type: Knowledge-Based
Contact Hours: 0.25
Release Date: May 29, 2026
Expiration Date: June 30, 2027
Activity Fee: Free for Members and Non-Members
CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher).
- Complete a specific activity evaluation.
Available Credit
- 0.25 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.